Analytical Data
-
基因名
SDK1
- Application
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7Z5N4
-
表达区间
Pro104~Thr476
-
分子量
45kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDK1, or Striatin-Dependent Kinase 1, is a protein that plays a crucial role in various cellular processes, including signal transduction, cellular signaling pathways, and cytoskeletal organization. Research into the reorganization of SDK1 has gained momentum due to its implications in neurodevelopmental disorders and its potential involvement in different pathologies, such as cancer and cardiac diseases. Understanding the structural and functional properties of SDK1, particularly following its reorganization, is essential for elucidating its biological significance. Investigating the restructured forms of SDK1 can provide insights into its interactions with other proteins, regulatory mechanisms, and the impact of post-translational modifications. Furthermore, the study of SDK1 reorganization can contribute to the development of therapeutic strategies aimed at modulating its activity in diseases linked to aberrant cell signaling. By exploring the mechanisms underlying SDK1 reorganization, researchers hope to identify novel biomarkers and targets for intervention, ultimately enhancing our understanding of its role in maintaining cellular homeostasis and its dysregulation in disease contexts.
